Clinical Trials Directory

Trials / Completed

CompletedNCT04603378

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects Using a Stable Isotope

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Kaleido Biosciences · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.

Conditions

Interventions

TypeNameDescription
OTHERKB195KB195 is a novel glycan
OTHERPolydextrosePolydextrose is an oligosaccharide
OTHERPullulanPullulan is an oligosaccharide
OTHERMaltodextrinMaltodextrin is a digestible carbohydrate

Timeline

Start date
2017-09-18
Primary completion
2017-11-28
Completion
2017-11-28
First posted
2020-10-26
Last updated
2020-10-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04603378. Inclusion in this directory is not an endorsement.

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects (NCT04603378) · Clinical Trials Directory